On this week’s Tech Nation, Moira speaks with the biotech companies at the BIO International Convention in San Diego. They meet in person for the first time in 3 years, where Dr. Gunn was able to speak with Paul Hastings, the Chair of BIO and the President & CEO of Nkarta, about the state of BIO and Nkarta’s work on delivering Natural Killer cells for cancer. Joe Panetta, President & CEO of Biocom California, brings insights into California as a whole and its relation globally, as well as the price of drugs. Dr. Richard Austin, founder and CEO of Reglagene talks about choosing their first-in-human drug for the brain cancer, Glioblastoma, and Dr. Chris Nave from Brandon Capital describes Polyactiva’s work in the treatment of glaucoma.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
